絞り込み

16752

広告

Pharmacokinetic considerations in the treatment of hypertension in risperidone-medicated patients - thinking of clinically relevant CYP2D6 interactions.

著者 Paulzen M , Haen E , Gründer G , Lammertz SE , Stegmann B , Schruers KR , Walther S , Schoretsanitis G
J Psychopharmacol.2016 08 ; 30(8):803-9.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (6view , 0users)

Full Text Sources

Medical

Miscellaneous

Treatment of arterial hypertension in patients with severe mental illnesses often results in polypharmacy, potentially leading to drug-drug interactions. The objective of the study was to analyse the in vivo inhibitory potential of two antihypertensive drugs, amlodipine and metoprolol on CYP2D6 catalysed 9-hydroxylation of risperidone (RIS).
PMID: 27251417 [PubMed - indexed for MEDLINE]
印刷用ページを開く Endnote用テキストダウンロード